BSI-045B

BIOLOGICAL2 trials

Sponsors

Biosion, Inc.

Conditions

Atopic Dermatitis

Phase 1

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

CompletedNCT05114889

Biosion, Inc.Atopic Dermatitis

Start: 2021-10-25End: 2023-02-15Updated: 2025-09-19

Phase 2

POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis

CompletedNCT05932654

Biosion, Inc.Atopic Dermatitis

Start: 2023-07-31End: 2024-09-18Updated: 2025-10-15